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Extracts from Jatropha curcas, a plant used in African traditional medicine for various diseases, were tested for cytotoxic
activity. The root extracts strongly reduced cell growth of tumor cells in vitro, a result consistent with the knowledge of
the application of these plant extracts in traditional medicine, especially to cure/ameliorate cancer. A selection of pure
diterpenoids existing in extracts from Jatropha species and isolated from J. curcas, for example, curcusone C, curcusone D,
multidione,15-epi-4Z-jatrogrossidentadion, 4Z-jatrogrossidentadion,4E-jatrogrossidentadion, 2-hydroxyisojatrogrossidion, and
2-epi-hydroxyisojatrogrossidion, were likewise tested, and they also showed strong cytotoxic activity. It turned out that these
extracts are highly active againstL5178ymouselymphoma cells and HeLa human cervix carcinoma cells, while they cause noneor
onlyverylowactivityagainstneuronalcell,forexample,PC12.Thesedataunderscorethatextracts fromJ.curcasorpure secondary
metabolites from the plant are promising candidates to be anticancer drug, combined with low neuroactive eﬀects.
1.Introduction
Jatropha curcas is a multipurpose (both medicinal and bi-
otechnologically important) plant and drought resistant
large shrub which is widely cultivated in Africa and Asia
for aesthetics as a live fence (Figure 1), as a source for
the production of biodiesel and for medicinal purposes
(reviewed in [1]). The plant belongs to the genus Jatropha
andfamilyEuphorbiaceae,knownfortheirtoxicconstituents
[2]. While the seeds are used for biodiesel production, the
root and rootbark are, among the other parts of the plant,
of medicinal relevance. The ﬁrst description of J. curcas was
published by von Linn´ e[ 3] who gave a few years later a more
comprehensive description of the genus Jatropha including
more species [4]F i g u r e s2(a), 2(d),a n d2(e). de Jussieu [5]
was the ﬁrst to describe the medical use of extracts from J.
curcas as being useful if given orally (tunc ad usus varios
usurpato) (Figures 2(b) and 2(f)).
In traditional medicine, this plant has been applied since
the earliest times for the cure of various ailments ranging
from simple fevers to infectious diseases including sexually
transmitted diseases in many African and Asian countries
[6,7].The diﬀerentpartsoftheplantservevariousmedicinal
uses. The seeds and the seed oil are used as purgative and
as a remedy for syphilis. In addition, the oil is used as a
substitute for diesel oil and as fuel [8, 9]. The leaves are
applied extensively in West African ethnomedical practice in
diﬀerent forms to cure various ailments like fever, mouth
infections, jaundice, guinea worm sores, and joint rheuma-
tism [10, 11]. The sap (latex) and crushed leaves have also
shown antiparasitic activity [12, 13]. Furthermore, the latex
contains compounds displaying antibacterial activity against2 Evidence-Based Complementary and Alternative Medicine
Figure 1: The plant Jatropha curcas, in the local language also
termed “lapalapa funfun”, is used in the South Western and Middle
Belt regions (Nigeria) as live fences. Extracts from the root and
rootbarks are used for medicinal applications.
Staphylococcus aureus [14]. Water extract of the branches
strongly inhibited HIV- induced cytopathic eﬀects with low
cytotoxicity [15]. In addition, the stems contain compounds
with strong antimicrobial activities, as proven by studies
carried outin Nigeria, and are used as chewing sticks in parts
of that country [16, 17]. Extracts of the stems have been
suggested to possess various biological activities including
anti-insect, antimicrobial, cytotoxic, anti-inﬂammatory, and
molluscicidal activities [18–25]. The roots of J. curcas are
used after decoction as a mouthwash for bleeding gums,
toothache, eczema, ringworm, and scabies, and to cure
dysentery and venereal diseases, like gonorrhea [6, 11].
Previous phytochemical studies on J. curcas resulted
in the isolation of many compounds including diterpenes,
sterols, ﬂavonoids, alkaloids, and peptides [28–34]. Many of
these compounds have shown various biological activities
ranging from antimicrobial to anticancer. Curcusone A
and B isolated from the stems showed anticancer activities
while curcusone B, furthermore, eﬀectively suppressed the
metastatic processes at nontoxic doses, [35]. It should be
stressed, however, that the anticancer activities of curcusone
C and D have not been reported previously.
In this paper, we report the cytotoxic/cytostaticactivities
ofroot extracts and chemical constituentsofJatropha species
against certain cancer cell lines along with evidence from
traditionalhealersontheuseofthisplantintreatingdiﬀerent
types of cancer. In contrast to the studies published to date,
in which pure compounds had been used for the cytotoxicity
studies, for example, curcin [36], we analyzed extracts from
theplantJ.curcas, similar tothose thatare usedfor treatment
in traditional medicine in the South West and Middle belt
regions of Nigeria. The data show that both the extracts
from J. curcas as well as its diterpenes are highly active
against tumor cells, L5178y mouse lymphoma cells, and
HeLa human cervix carcinoma cells, combined with a low
eﬀect on the neuronal cell line PC12.
2.Materialsand Methods
2.1. Plant Materials. Whole plants of Jatropha curcas
(Euphorbiaceae) were collected from the campus of the Uni-
versity of Ibadan, Ibadan, Nigeria in 2006. The plants were
authenticated at the Herbarium of the Forestry Research
Institute, Ibadan, Nigeria. (Herbarium Voucher Number:
FHI 107674). The roots were separated from the rest of the
plant, dried, and ground.
2.2. Extraction of Plant Materials. A known amount of the
dried, ground root of J. curcas (1.0kg) was extracted with
n-hexane, ethyl acetate, and methanol to give the respective
crude extracts which were concentrated in vacuo.T h ey i e l d s
of the extracts were as follows: hexane 10.5g, ethyl acetate
11.2g, and methanol 42.3g.
2.3. Fractionation of the Extracts and Isolation of the Pure
Compounds. Based on the results of the in-vitro cytotox-
icity assay of the extracts, the hexane and ethyl acetate
extracts J. curcas were subjected to fractionation by column
chromatography. The fractions obtained were subjected
to further assays before they were puriﬁed by HPLC to
obtain the pure compounds. Details of the procedures and
characterisation of the compounds have been reported [37].
Fourteen compounds were isolated from the extracts, and
some of these compounds had been isolated from Jatropha
podagrica and Jatropha multiﬁda (Euphorbiaceae),medicinal
plants closely related to J. curcas and which also grows in
Nigeria [21, 22, 38, 39].
2.4. Conﬁrmation from the Herbalists on the Eﬃcacy of J.
curcas as Anticancer Agents. Two traditional healers and
one traditional pediatric pharmacist (herbal seller) were
thoroughly interviewed to collect more detailed information
ontheusesand eﬃcaciesoftheplantintraditional medicine.
The interviews were conducted orally in the vernacular of
the people, and the responses were transcribed on paper and
subsequently translated by an anthropologist for accuracy.
They gave useful information on the diﬀerent applications
involving J. curcas to treat various diseases including cancer
(Figures 2 and 3).
2.5. Determination of Cytotoxic Activity. The extracts ob-
tained were subjected to an in-vitro cytotoxicity assay apply-
ing the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tet-
razolium bromide] (Sigma-Aldrich, Taufkirchen; Germany)
method [39–41]. Three diﬀerent cell lines were routinely
used for activity testing: L5178y mouse lymphoma cells [42],
PC12 rat adrenal medulla pheochromocytoma cells [43],
and also HeLa human cervix carcinoma cells [44]. The cells
were grown in RPMI 1640 medium (Gibco BRL, Eggenstein;
Germany), supplemented with 10mM Hepes [hydroxyethyl-
piperazineethane-sulfonic acid], 10% fetal calf serum (FCS)
(PAA, C¨ olbe, Germany) for L5178y and HeLa cells, or 5%Evidence-Based Complementary and Alternative Medicine 3
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Figure 2:The ﬁrstdescriptions ofJ. curcas. (a)Description ofthespecies by vonLinn´ e[3].(b)FirstdescriptionofJ. curcas asamedicalplant
by de Jussieu [5]. (c) Recipe describing J. curcas extracts as antitumor medicine form the traditional healer, Baba Reke. (d, e) Description of
the genus Jatropha by von Linn´ e[ 3, 4], already including 13 species (f).
horse serum for PC12 cells, and 0.1% gentamycin. All cells
were routinely passaged twice weekly. The cells were kept in
a humidiﬁed atmosphere of 95% air and 5% CO2 at 37◦C.
2.6. MTT Assay. To estimate the EC50 values, L5178y, PC12,
or HeLa cells were incubated for 72hrs in the presence of
diﬀerent concentrations (0.1; 0.3; 1.0; 3.0, and 10.0µg/mL)
of the respective extracts. The ﬁnal volumes in the assays
were 200µL. All extracts were dissolved in DMSO [dimethyl
sulfoxide] (stock solution 10mg/mL) and stored at −20◦C.
The viability of the cells was determined using the MTT
colorimetric assay system. The evaluation was performed in
96-well plates at 595nm using an ELISA plate reader, after
overnight incubation at 37◦C as described [45].
2.7. Statistics. The 50% eﬀective concentration (EC50), rep-
resenting that concentration at which the growth rate of the
infected cells was reduced by 50%, was estimated by logit
regression [26], as described [27]. The means (±SD) from
10 separate experiments are given.
3.Resultsand Discussion
3.1. Biomedical Application in Traditional Medicine in the
South West/Middle Belt Part of Nigeria. Over 30 diﬀerent
traditional healers and herbal sellers have been interviewed.
The interviews were conducted orally in the vernacular
of the people, and their responses were transcribed on
paper and subsequently translated by an anthropologist for
accuracy. The following three representative recipes should
be documented here.
The traditional healer Alhaji Oloogun (Figure 3(a))
gave a recipe for the amelioration of skin inﬂammations
(Figure 2(c)) as follows. The roots must be minced and
are then extracted together with 1:100(w/w) Yoruba small
sized local pepper with aqueousethanolic solvent. The slurry
is thoroughly mixed 1:5(v/v) with local black soap. This
formulation is then used for everyday bathing in order to
treat skin rashes and infections very eﬀectively.
From the second traditional healer, Baba Reke (Fig-
ure 3(b)), a recipe was obtained that has frequently been
applied to treat sexually transmitted diseases. The J. curcas
roots are cut into small pieces and then soaked with an
aqueous alcoholic solvent for two to three days. The cleared4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Medical impact of extracts from J. curcas, as learned from interviews with (a) the traditional healer, Alhaji Oloogun,Ilorin (Kwara
state, Nigeria), (b) Baba Reke (Ilorin),and (c) Iya Igbeti, a female Yoruba traditional pediatric pharmacist at the New Market at Ilorin. They
described how extracts of this plant, supplemented with black pepper or local black soap (as prepared by the Yoruba tribes of Nigeria),
are used as traditional medicine which may also increase appetite and promote secretion, properties which have also been documented in
modern medicinal textbooks [50].
extract is used as a drink; small glass cups (about 10mL
each) of this extract must be drunk twice daily, morning and
night. By the experience of this healer, this formulation was
successful against any kind of cancer and several types of
sexually transmitted diseases, for example, gonorrhea.
Finally, from Iya Igbeti, a female Yoruba traditional pedi-
atric pharmacist (Figure 3(c)) ,ar e c i p ef o rt h et r e a t m e n t /
amelioration of a broad spectrum of local diseases was
obtained. The aqueous extract is again prepared from J. cur-
cas roots, togetherwith the following components; ﬁrst, with
the dried outer parts of the Cassia tora f r u i t s ,a l s ot e r m e d
“eru olounla” or “alamo,” and, second, with dried stem bark
of guinea corn, Sorghum caudatum, “karandaﬁ” by using
small quantity of each (1:10w/w). In order to increase the
eﬃciency of the extraction, the slurry is supplemented with
potash (1:10v/w) and natural cotton wool (1:10v/w). The
suspension is then boiled at 70◦C( 6 0m i n )a n ds u b s e q u e n t l y
heatedat 100◦Cforanother60min after additionofan equal
volume of clean water until it is well cooked. Care should be
taken not to allow the extract to rapidly chill. The patients
are advised to drink a small glass cup of that formulation
twice daily in the morning and night. It was found to be
eﬀective against cancer of the intestine, stomach upset, and
rheumatism as well as diarrhea.
3.2. Cytostatic Activity of the Extracts. The extracts obtained
showed strong cytotoxic activity against the three cell
lines with eﬀective inhibition higher than 100% even at
concentrations below 5µg/mL. This concentration had been
Table 1: Percentagegrowth inhibitionby 50%(EC50:e ﬀective dose,
causing50% reduction ofcell density during the 72 hrs incubation)
by extracts from J. curcas roots. The following extracts were tested:
hexane extract (JCRBH) and ethyl acetate extract (JCRBEA) as well
as methanol extract (JCRBM). The three cells lines L5178y, PC12,
and HeLa were used for the experiments.
Extracts Tumor cell lines, inhibitory concentration EC50 (µg/mL)
L5178y PC12 HeLa
JCRBH 0.82 ± 0.1 5.7 ± 0.6 1.7 ± 0.1
JCRBEA 2.2 ± 0.2 >10.0 2.5 ± 0.3
JCRBM 3.7 ± 0.3 >10.0 3.1 ± 0.3
set as a borderline, below which a compound/extract is
termed cytotoxic [46]. The data summarized in Table 1
and in Figure 4(a) show that the hexane extract (JCRBH)
possessed highest inhibitory activity. It is remarkable that
besides the strong inhibition of L5178y cells, also HeLa cells
were aﬀectedby thehexane extract. Most cytostaticdrugs are
much less inhibitory on HeLa cells than on L5178y cells [45].
The extracts prepared with ethyl acetate and methanol were
less eﬀective. Remarkable is the weaker eﬀects of all three
extracts, especially of those obtained with the more polar
solvents, (ethyl acetate and methanol) on PC12 cells. Since
this cell line [47] is of neuronal origin it can be expected
that also in vivo these extracts might be less/if at all toxic on
neuronal tissue.Evidence-Based Complementary and Alternative Medicine 5
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Figure 4: (a) Cytotoxic activity of J. curcas extracts. Further details
are given in Table 1. (b) Cytotoxic activity of pure compounds
from extracts of J. curcas. The pure compounds had been isolated
from root extracts as described under Section 2.T h em e a n so f1 0
diﬀerent experiments (±SD) are given as EC50:e ﬀective doses; see
also Table 2 for further information.
Previously, some pure compounds have been isolated
from organic extracts of J. curcas and other Jatropha species
[30, 38, 48, 49]. Here, we isolated fourteen diterpenes by
bioassay-guided techniques as described earlier [37]. These
compounds were tested for their inhibitory activities on the
L5178ycellline(Table2;Figure4(b)).Someofthediterpenes
showed very strong inhibitory activities. Especially high was
theinhibitionforcurcusoneCwithEC50 of0.08µg/mL.Four
curcusones have already earlier been isolated from J. curcas
out of which two, namely curcusone A and B, have shown
cytotoxic activities [35]. The present study is, however, the
ﬁrst report of the cytotoxic activities for curcusone C and D.
The highly potent activities exhibited by curcusone C and D
suggest that these compounds could be developed further as
anticancer drugs. Furthermore, their modes of action have
to be investigated; for curcusone B, an antimetastatic activity
has already been described [35].
Leaves: fever, infection, tumor
Seeds: oil, infectious diseases, biofuel
Latex: haemostatic agent
Roots: eczema, veneral diseases
Figure 5: Jatropha curcas: from leaves, latex, roots, and seeds
diﬀerent bioactive or commercially important ingredients have
been extracted; schematic representation. For details, see text.
Table 2: Cytotoxic activity of compounds isolated from Jatropha
curcas root extracts. The EC50 values are given here; the SD’s of the
respective values are less than 15%.
Compounds EC50 (µg/mL) for L5178y cells
Curcusone C 0.08
Curcusone D 0.16
2-Hydroxyisojatrogrossidion 0.20
Curcusone A 0.21
2-epi-hydroxyisojatrogrossidion 0.24
Curcusone B 0.27
4Z-jatrogrossidentadion 0.60
15-epi-4E-jatrogrossidentadion 0.85
4E-jatrogrossidentadion 2.10
Acetoxyjatropholone 2.50
Multidione 5.50
Jatropholone 7.50
Curcusone E >10
Spirocurcasone >10
In conclusion, the present study underscores that the
plant J. curcas produces a series of cytostatically active
compounds; Figure 5. In view of the present ﬁndings that
even crude extracts from this plant are highly active, and
relatively more active than some of the hitherto known
secondary metabolitesfromthisplant,itcanbeexpectedthat
more new compounds with higher cytostatic activity can be
isolated in future. However, it should also be considered that
the active compounds in the extracts may act synergistically
in such a way that the inhibitory eﬀects of the extracts are
higher than that of their components. Such a potentiation of
individual compounds in extracts, especially from herbs has
been discussed before [50, 51].6 Evidence-Based Complementary and Alternative Medicine
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